Review
doi: 10.1586/14737175.4.1.17.
Mitoxantrone (Novantrone) in multiple sclerosis: new insights
Affiliations
- PMID: 15853611
- DOI: 10.1586/14737175.4.1.17
Item in Clipboard
Review
Mitoxantrone (Novantrone) in multiple sclerosis: new insights
Expert Rev Neurother.
2004 Jan.
Abstract
The conclusions of a recent study of mitoxantrone (Novantrone) in multiple sclerosis and the approval of several health authorities support its use in patients with active relapsing-remitting or secondary progressive multiple sclerosis. This drug profile provides an outline on relevant preclinical and clinical studies, discusses relevant side effects of the compound and places mitoxantrone in the context of other therapeutic approaches available against this disabling disorder.
Similar articles
-
Therapeutic role of mitoxantrone in multiple sclerosis.Pharmacol Ther. 2006 Jan;109(1-2):198-209. doi: 10.1016/j.pharmthera.2005.07.002. Epub 2005 Aug 10. Pharmacol Ther. 2006. PMID: 16095713 Review.
-
[Mitoxantrone for the treatment of patients with multiple sclerosis].Brain Nerve. 2009 May;61(5):575-80. Brain Nerve. 2009. PMID: 19514518 Review. Japanese.
-
Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis.Eur Neurol. 2011;65(1):40-5. doi: 10.1159/000323013. Epub 2010 Dec 22. Eur Neurol. 2011. PMID: 21196739
-
Management of worsening multiple sclerosis with mitoxantrone: a review.Clin Ther. 2006 Apr;28(4):461-74. doi: 10.1016/j.clinthera.2006.04.013. Clin Ther. 2006. PMID: 16750460 Review.
-
Mechanisms of mitoxantrone in multiple sclerosis--what is known?J Neurol Sci. 2004 Aug 15;223(1):25-7. doi: 10.1016/j.jns.2004.04.015. J Neurol Sci. 2004. PMID: 15261556 Review.
Cited by
-
Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study.Med Oncol. 2023 Oct 20;40(11):337. doi: 10.1007/s12032-023-02203-6. Med Oncol. 2023. PMID: 37864019
-
[Choice of early and escalation treatment options for multiple sclerosis].Nervenarzt. 2008 Oct;79(10):1123-4,1126-8,1130-2 passim. doi: 10.1007/s00115-008-2521-3. Nervenarzt. 2008. PMID: 18806985 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
